ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 59 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2017. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $29,000 | -88.1% | 22,311 | -80.7% | 0.03% | -87.3% |
| Q1 2019 | $244,000 | -2.0% | 115,724 | +4.5% | 0.20% | -12.4% |
| Q4 2018 | $249,000 | -41.1% | 110,757 | -8.4% | 0.23% | -31.8% |
| Q3 2018 | $423,000 | -15.9% | 120,940 | -23.1% | 0.34% | -20.0% |
| Q2 2018 | $503,000 | -0.2% | 157,301 | +9.3% | 0.43% | -3.2% |
| Q1 2018 | $504,000 | -21.9% | 143,925 | -1.8% | 0.44% | -17.4% |
| Q4 2017 | $645,000 | -13.9% | 146,581 | +2.2% | 0.54% | -18.4% |
| Q3 2017 | $749,000 | -1.3% | 143,377 | -1.7% | 0.66% | -2.8% |
| Q2 2017 | $759,000 | +31.3% | 145,909 | +7.2% | 0.68% | +31.8% |
| Q1 2017 | $578,000 | +31.4% | 136,077 | -2.6% | 0.51% | +29.5% |
| Q4 2016 | $440,000 | -6.4% | 139,746 | +1.9% | 0.40% | -10.2% |
| Q3 2016 | $470,000 | – | 137,132 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |